Home ⟩ Insights

Insights

health-care

min read • January 8, 2026

Cannabis Is No Longer Just About Legalization and Money. Science Is Shifting the Conversation

min read • November 20, 2025

Weed May Reduce How Much You Drink, Researchers Say

min read • November 4, 2025

Pharma Meets Cannabis Ahead Of Potential Cannabis Rescheduling, Here’s More About New Partnership

min read • October 20, 2025

Cannabis Policy Shifts Across US: Reinvestment, Reform & Debate Highlights

2 min read • October 1, 2025

Chronic Lower Back Pain? This Cannabis-Based Therapy Might Be The Game-Changer

3 min read • July 3, 2025

MIRA Pharmaceuticals’ Marijuana Analog Mira-55 Shows Potent Pain Relief In Preclinical Study, Stock Jumps 50% After Hours

3 min read • April 16, 2025

Chamath Palihapitiya Says Marijuana Should Never Have Been Legalized: Turning ‘Our Kids Into Zombies’

13 min read • March 7, 2025

This Week In Cannabis: Snoop’s Beverage Empire, Earnings, M&A, International News And More

7 min read • February 17, 2025

EXCLUSIVE: Ex-Rep. Kinzinger On GOP’s Internal War Over Drug Policy, Cannabis, Psychedelics – ‘Quite Likely Legal In 5-10 Years’

3 min read • February 10, 2025

Could Cannabis Compounds Outperform Diabetes Drugs? Early Findings Show Potential, But More Research Is Needed

7 min read • February 5, 2025

Cannabis Takes On Superbugs: Could This New Drug ‘Change Infection Treatment Forever’?

2 min read • January 10, 2025

Cannabis/Beer Company Tilray Outlines Plan To Reduce Its Beverage Portfolio, Reports Mixed Q2 Earnings

Latest Headlines

3 min read • October 16, 2026

Inside Cronos’ 58% Revenue Growth: Market Share and Expansion

3 min read • October 15, 2026

DEA Cannabis Rescheduling Faces New October 21 Deadline After Judge Weighs Reopening Hearing

2 min read • October 15, 2026

Glass House Eyes European Cannabis Exports After GACP Certification

2 min read • October 15, 2026

“Curaleaf’s Revised Offer Still Does Not Reflect the Value”: Aurora Rejects $5 Hostile Bid

6 min read • October 15, 2026

Organigram Wants More Than Revenue From Germany. It Wants the Whole Margin

5 min read • October 14, 2026

The Real Cost of a Cannabis Gummy: Azuca’s CEO on Manufacturing Margins and Scale

5 min read • October 14, 2026

Cannabis Products Have to Earn Their Shelf Space. Curio Wellness Explains How

min read • October 13, 2026

Cronos Has a $1 Billion War Chest. Zuanic Sees Up to 3x Upside

5 min read • October 13, 2026

Marijuana Rescheduling Hits a New Deadline Today, With Court Fight Stretching Into 2027

4 min read • October 9, 2026

Vireo Secures $60 Million at 8.5% to Refinance Cannabis Facilities in New York and Florida

6 min read • October 9, 2026

“This Defies All Fiduciary Logic”: Curaleaf Fires Back at Aurora; Rival Deal Rumors Swirl

4 min read • October 9, 2026

Aurora Doubles German Cannabis Output, Giving Investors More to Weigh in Curaleaf Takeover

Browse By Channels

After-Hours Center

Analyst Ratings

Be Your Own Boss

Broad U.S. Equity ETFs

california cannabis

cannabis cultivation

cannabis earnings

Christopher Dillis

Congress cannabis

Earnings Misses

Emerging Market ETFs

Emerging Markets

Entrepreneurship

Federal Reserve

Financial Advisors

first quarter earnings

germany cannabis

hemp legalization

hemp regulation

IgniteIt Events

illegal cannabis farms

intoxicating hemp-derived products

Intraday Update

Macro Economic Events

Macro Notification

Market-Moving Exclusives

Movers & Shakers

Personal Finance

Pre-Market Outlook

Small Cap Analysis

Success Stories

UC Berkeley Cannabis Research Center

unlicensed cannabis

Join the Cannabis Revolution

Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.

(opens in a new tab)